intra-cardiac echocardiography (ICE), or transesophageal echocardiography (TEE)

OTHER2 trials

Sponsors

Corvia Medical

Conditions

Heart FailureHeart Failure, Diastolic

Unknown Phase

REDUCE LAP-HF TRIAL II

Active, not recruitingNCT03088033

Corvia MedicalHeart Failure

Start: 2017-06-01End: 2026-09-30Target: 608Updated: 2023-02-22

RESPONDER-HF Trial

Active, not recruitingNCT05425459

Corvia MedicalHeart Failure, Heart Failure, Diastolic

Start: 2022-11-17End: 2031-03-01Target: 750Updated: 2026-03-18

Related Papers

Expanded Definition of Worsening Heart Failure

JACC Heart Failure2025-07-252 citations

Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials.

2024-09-032 citations

2-Year Outcomes of an Atrial Shunt Device in HFpEF/HFmrEF: Results From REDUCE LAP-HF II.

2024-06-269 citations

Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction

JAMA Cardiology2024-04-1719 citations

Atrial Fibrillation Burden and Atrial Shunt Therapy in Heart Failure With Preserved Ejection Fraction.

2023-07-196 citations

Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection Fraction.

2023-03-2025 citations

Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.

2022-02-01185 citations